共 50 条
- [31] Real-World Trends of Cytokine Release Syndrome and Neurologic Events, and Pattern of Their Management Among Patients Receiving Axicabtagene Ciloleucel for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) in the US: A CIBMTR ReportBLOOD, 2024, 144 : 528 - 528Wang, JiashengBhaskar, ShakthiAdedokun, BabatundeOluwole, Olalekan O.Metheny, LelandMoskop, AmyJacobson, Caron A.Shouse, GeoffreyAhmed, SairahGhobadi, ArminDahiya, SaurabhYan, JialiHu, Zhen-HuanBest, TimothyKim, Jenny J.Mirjah, Debbie L.Pasquini, Marcelo C.Locke, Frederick L.
- [32] Axicabtagene Ciloleucel Compared to Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma in the Real World Setting in SpainBLOOD, 2021, 138Kwon, MiIacoboni, GloriaLuis Reguera, JuanLopez Corral, LuciaHernani, RafaelGuerreiro, ManuelCarolina Caballero, AnaOrtiz-Maldonado, ValentinSanchez, Jose M.Paviglianiti, AnnalisaSancho, Juan-ManuelBastos-Oreiro, MarianaOarbeascoa, GillenMartin Rojas, Reyes MariaCatala, EvaDelgado Serrano, JavierMussetti, AlbertoSanz, JaimeCalbacho, MariaBailen, RebecaBriones, JavierHernandez Boluda, Juan CarlosMartin Garcia-Sancho, AlejandroDiez-Martin, Jose L.Barba, Pere
- [33] ECONOMIC EVALUATIONS IN RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): CHALLENGES FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONSVALUE IN HEALTH, 2023, 26 (12) : S334 - S334Forbes, C.Pustulka, IZuchinali, P.Kumar, J.
- [35] CURRENT EPCORITAMAB PLUS RITUXIMAB AND LENALIDOMIDE (R2) PERCEPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)VALUE IN HEALTH, 2024, 27 (12) : S342 - S342Levine, E.Gentile, D.Swain, R.Bone, R. N.Jennings-Zhang, L.Jeune-Smith, Y.Feinberg, B.
- [36] Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)MOLECULAR THERAPY, 2020, 28 (04) : 577 - 577Topp, Max S.van Meerten, TomHout, RochMinnema, Monique C.Milpied, NoelLugtenburg, Pieternella J.Thieblemont, CatherineWermke, MartinSong, Kevin W.Avivi, IritKuruvilla, JohnDuehrsen, UlrichChu, RongZheng, LianqingPlaks, VickiKerber, AnneKersten, Marie Jose
- [37] Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphomaJOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (07)Hao, YanniHsu, Wei-ChunParzynski, Craig S.Degtyarev, EvgenyHampson, Lisa, VMasood, AishaWu, Wen-Hsing
- [38] Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-ImmunotherapyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S442 - S443Nastoupil, Loretta J.Andersen, ClarkAyers, AmyWang, YucaiHabermann, Thomas M.Chihara, DaiKahl, Brad S.Link, Brian K.Ayyappan, SabarishCohen, Jonathon B.Martin, PeterLossos, Izidore S.Casulo, CarlaLin, RuitaoLi, ZiyiLarson, Melissa A.Maurer, Matthew J.Huynh, LynnGao, ChiRamasubramanian, RamyaDuh, Mei ShengMutebi, AlexWang, TongshengJun, MonikaWang, AnthonyKamalakar, RajeshKalsekar, AnupamaCerhan, James R.Flowers, Christopher R.
- [39] Real-World Patient-Reported and Neurocognitive Outcomes in the Year After Axicabtagene CiloleucelTRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (03): : 157e1 - 157e13Hoogland, Aasha I.Li, XiaoyinModi, KarnavWelniak, TaylorRodriguez, YveliseIrizarry-Arroyo, NathalyOswald, Laura B.Snider, Julia T.Wade, Sally W.Chavez, JulioCorallo, SalvatoreBooth-Jones, MargaretJain, Michael D.Locke, Frederick L.Jim, Heather S. L.
- [40] Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicityBLOOD, 2024, 143 (26) : 2722 - 2734Locke, Frederick L.Siddiqi, TanyaJacobson, Caron A.Ghobadi, ArminAhmed, SairahMiklos, David B.Perales, Miguel -AngelMunoz, JavierFingrut, Warren B.Pennisi, MartinaGauthier, JordanShadman, MazyarGowda, LohithMirza, Abu-SayeefAbid, Muhammad BilalHong, SangheeMajhail, Navneet S.Kharfan-Dabaja, Mohamed A.Khurana, ArushiBadar, TalhaLin, YiBennani, N. NoraHerr, Megan M.Hu, Zhen-HuanWang, Hai -LinBaer, AnjaniBaro, ElandeMiao, HarrySpooner, ClareXu, HairongPasquini, Marcelo C.